Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis

Abstract

Transforming growth factor-β (TGF-β) superfamily members signal via membrane-bound heteromeric serine–threonine kinase receptor complexes. Upon ligand-binding, receptor activation leads to phosphorylation of cytoplasmic protein substrates of the Smad family. Following phosphorylation and oligomerization, the latter move into the nucleus to act as transcription factors to regulate target gene expression. TGF-β responses are not solely the result of the activation Smad cascade, but are highly cell-type specific and dependent upon interactions of Smad signaling with a variety of other intracellular signaling mechanisms, initiated or not by TGF-β itself, that may either potentiate, synergize, or antagonize, the rather linear TGF-β/Smad pathway. These include, (a), regulation of Smad activity by mitogen-activated protein kinases (MAPKs), (b), nuclear interaction of activated Smads with transcriptional cofactors, whether coactivators or corepressors, that may be themselves be regulated by diverse signaling mechanisms, and (c), negative feedback loops exerted by inhibitory Smads, transcriptional targets of the Smad cascade. This review focuses on how MAPKs modulate the outcome of Smad activation by TGF-β, and how cross-signaling mechanisms between the Smad and MAPK pathways may take place and affect cell fate in the context of carcinogenesis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Akhurst RJ and Balmain A . (1999). J. Pathol., 187, 82–90.

  • Akhurst RJ and Derynck R . (2001). Trends Cell Biol., 11, S44–S51.

  • Angel P and Karin M . (1991). Biochim. Biophys. Acta, 1072, 129–157.

  • Arnulf B, Villemain A, Nicot C, Mordelet E, Charneau P, Kersual J, Zermati Y, Mauviel A, Bazarbachi A and Hermine O . (2002). Blood, 100, 4129–4138.

  • Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS and Sonenshein GE . (2003). Oncogene, 22, 412–425.

  • Atfi A, Djelloul S, Chastre E, Davis R and Gespach C . (1997). J. Biol. Chem., 272, 1429–1432.

  • Birkey Reffey S, Wurthner JU, Parks WT, Roberts AB and Duckett CS . (2001). J. Biol. Chem., 16, 16.

  • Brodin G, Ahgren A, ten Dijke P, Heldin CH and Heuchel R . (2000). J. Biol. Chem., 275, 29023–29030.

  • Brown JD, DiChiara MR, Anderson KR, Gimbrone Jr MA and Topper JN . (1999). J. Biol. Chem., 274, 8797–8805.

  • Calonge MJ and Massagué J . (1999). J. Biol. Chem., 274, 33637–33643.

  • Chang L and Karin M . (2001). Nature, 410, 37–40.

  • Chung KY, Agarwal A, Uitto J and Mauviel A . (1996). J. Biol. Chem., 271, 3272–3278.

  • Davis RJ . (2000). Cell, 103, 239–252.

  • de Caestecker MP, Parks WT, Frank CJ, Castagnino P, Bottaro DP, Roberts AB and Lechleider RJ . (1998). Genes Dev., 12, 1587–1592.

  • de Caestecker MP, Piek E and Roberts AB . (2000). J. Natl. Cancer Inst., 92, 1388–1402.

  • Derynck R, Akhurst RJ and Balmain A . (2001). Nat. Genet., 29, 117–129.

  • Derynck R and Feng XH . (1997). Biochim. Biophys. Acta, 1333, F105–F150.

  • Derynck R, Zhang Y and Feng XH . (1998). Cell, 95, 737–740.

  • Derynck R and Zhang YE . (2003). Nature, 425, 577–584.

  • Di Guglielmo GM, Le Roy C, Goodfellow AF and Wrana JL . (2003). Nat. Cell Biol., 5, 410–421.

  • Dowdy SC, Mariani A and Janknecht R . (2003). J. Biol. Chem., 278, 44377–44384.

  • Dumont N, Bakin AV and Arteaga CL . (2003). J. Biol. Chem., 278, 3275–3285.

  • Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T and Miyazono K . (2001). J. Biol. Chem., 276, 12477–12480.

  • Edlund S, Bu S, Schuster N, Aspenstrom P, Heuchel R, Heldin NE, ten Dijke P, Heldin CH and Landstrom M . (2003). Mol. Biol. Cell, 14, 529–544.

  • Edlund S, Landstrom M, Heldin CH and Aspenstrom P . (2002). Mol. Biol. Cell, 13, 902–914.

  • Eferl R and Wagner EF . (2003). Nat. Rev. Cancer, 3, 859–868.

  • Engel ME, Datta PK and Moses HL . (1998). J. Cell. Biochem. Suppl., 31, 111–122.

  • Engel ME, McDonnell MA, Law BK and Moses HL . (1999). J. Biol. Chem., 274, 37413–37420.

  • Gold LI . (1999). Crit. Rev. Oncog., 10, 303–360.

  • Hai T and Curran T . (1991). Proc. Natl. Acad. Sci. USA, 88, 3720–3724.

  • Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K and Nishida E . (1999). J. Biol. Chem., 274, 27161–27167.

  • Hannon GJ and Beach D . (1994). Nature, 371, 257–261.

  • Harlin H, Reffey SB, Duckett CS, Lindsten T and Thompson CB . (2001). Mol. Cell Biol., 21, 3604–3608.

  • Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone Jr MA, Wrana JL and Falb D . (1997). Cell, 89, 1165–1173.

  • Hazzalin CA and Mahadevan LC . (2002). Nat. Rev. Mol. Cell Biol., 3, 30–40.

  • Hill CS . (1999). Int. J. Biochem. Cell. Biol., 31, 1249–1254.

  • Hocevar BA, Brown TL and Howe PH . (1999). EMBO J., 18, 1345–1356.

  • Hu PP, Shen X, Huang D, Liu Y, Counter C and Wang XF . (1999). J. Biol. Chem., 274, 35381–35387.

  • Ip YT and Davis RJ . (1998). Curr. Opin. Cell Biol., 10, 205–219.

  • Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin CH and ten Dijke P . (2003). J. Biol. Chem., 278, 3751–3761.

  • Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H and Grunert S . (2002). J. Cell. Biol., 156, 299–313.

  • Javelaud D and Mauviel A . (2004). Int. J. Biochem. Cell Biol., 36, 1161–1165.

  • Johansson N, Ala-aho R, Uitto V, Grenman R, Fusenig NE, Lopez-Otin C and Kahari VM . (2000). J. Cell Sci., 113 (Part 2), 227–235.

  • Jonk LJ, Itoh S, Heldin CH, ten Dijke P and Kruijer W . (1998). J. Biol. Chem., 273, 21145–21152.

  • Kakonen SM, Selander KS, Chirgwin JM, Yin JJ, Burns S, Rankin WA, Grubbs BG, Dallas M, Cui Y and Guise TA . (2002). J. Biol. Chem., 277, 24571–24578.

  • Kamaraju AK and Roberts AB . (2005). J. Biol. Chem., 280, 1024–1036.

  • Karin M, Liu Z and Zandi E . (1997). Curr. Opin. Cell Biol., 9, 240–246.

  • Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH and Wrana JL . (2000). Mol. Cell, 6, 1365–1375.

  • Kim ES, Kim MS and Moon A . (2004). Int. J. Oncol., 25, 1375–1382.

  • Kim ES, Kim MS and Moon A . (2005). Cytokine, 29, 84–91.

  • Kretzschmar M, Doody J, Timokhina I and Massagué J . (1999). Genes Dev., 13, 804–816.

  • Lehmann K, Janda E, Pierreux CE, Rytomaa M, Schulze A, McMahon M, Hill CS, Beug H and Downward J . (2000). Genes Dev., 14, 2610–2622.

  • Lowes VL, Ip NY and Wong YH . (2002). Neurosignals, 11, 5–19.

  • Lutz M and Knaus P . (2002). Cell Signal, 14, 977.

  • Massagué J and Chen YG . (2000). Genes Dev., 14, 627–644.

  • Mauviel A, Chen Y, Dong W, Evans CH and Uitto J . (1993). Curr. Biol., 3, 822–831.

  • Mauviel A, Chung KY, Agarwal A, Tamai K and Uitto J . (1996). J. Biol. Chem., 271, 10917–10923.

  • Mazars A, Lallemand F, Prunier C, Marais J, Ferrand N, Pessah M, Cherqui G and Atfi A . (2001). J. Biol. Chem., 276, 36797–36803.

  • Miyazono K, ten Dijke P and Heldin CH . (2000). Adv. Immunol., 75, 115–157.

  • Mori S, Matsuzaki K, Yoshida K, Furukawa F, Tahashi Y, Yamagata H, Sekimoto G, Seki T, Matsui H, Nishizawa M, Fujisawa J and Okazaki K . (2004). Oncogene, 23, 7416–7429.

  • Mucsi I, Skorecki KL and Goldberg HJ . (1996). J. Biol. Chem., 271, 16567–16572.

  • Nicolas FJ, De Bosscher K, Schmierer B and Hill CS . (2004). J. Cell. Sci., 117, 4113–4125.

  • Oft M, Akhurst RJ and Balmain A . (2002). Nat. Cell Biol., 4, 487–494.

  • Oft M, Heider KH and Beug H . (1998). Curr. Biol., 8, 1243–1252.

  • Oft M, Peli J, Rudaz C, Schwarz H, Beug H and Reichmann E . (1996). Genes Dev., 10, 2462–2477.

  • Ohshima T and Shimotohno K . (2003). J. Biol. Chem., 278, 50833–50842.

  • Penheiter SG, Mitchell H, Garamszegi N, Edens M, Dore Jr JJ and Leof EB . (2002). Mol. Cell Biol., 22, 4750–4759.

  • Perlman R, Schiemann WP, Brooks MW, Lodish HF and Weinberg RA . (2001). Nat. Cell Biol., 3, 708–714.

  • Pessah M, Marais J, Prunier C, Ferrand N, Lallemand F, Mauviel A and Atfi A . (2002). J. Biol. Chem., 28, 28.

  • Pessah M, Prunier C, Marais J, Ferrand N, Mazars A, Lallemand F, Gauthier JM and Atfi A . (2001). Proc. Natl. Acad. Sci. USA, 98, 6198–6203.

  • Quan T, He T, Voorhees JJ and Fisher GJ . (2005). J. Biol. Chem., 280, 8079–8085.

  • Ravanti L, Hakkinen L, Larjava H, Saarialho-Kere U, Foschi M, Han J and Kahari VM . (1999). J. Biol. Chem., 274, 37292–37300.

  • Reynisdottir I, Polyak K, Iavarone A and Massagué J . (1995). Genes Dev., 9, 1831–1845.

  • Roberts AB, Kim SJ, Noma T, Glick AB, Lafyatis R, Lechleider R, Jakowlew SB, Geiser A, O'Reilly MA, Danielpour D and Sporn MB . (1991). Ciba Found. Symp., 157, 7–15.

  • Sanchez-Capelo A . (2005). Cytokine Growth Factor Rev., 16, 15–34.

  • Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T and Ishii S . (1999). J. Biol. Chem., 274, 8949–8957.

  • Shaulian E and Karin M . (2001). Oncogene, 20, 2390–2400.

  • Shaulian E and Karin M . (2002). Nat. Cell Biol., 4, E131–E136.

  • Shi W, Sun C, He B, Xiong W, Shi X, Yao D and Cao X . (2004). J. Cell Biol., 164, 291–300.

  • Shi Y and Massague J . (2003). Cell, 113, 685–700.

  • Siegel PM and Massague J . (2003). Nat. Rev. Cancer, 3, 807–821.

  • Smeal T, Hibi M and Karin M . (1994). EMBO J., 13, 6006–6010.

  • Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K and Saito H . (2002). EMBO J., 21, 6473–6482.

  • ten Dijke P and Hill CS . (2004). Trends Biochem. Sci., 29, 265–273.

  • Tian F, Byfield SD, Parks WT, Stuelten CH, Nemani D, Zhang YE and Roberts AB . (2004). Cancer Res., 64, 4523–4530.

  • Tian F, DaCosta Byfield S, Parks WT, Yoo S, Felici A, Tang B, Piek E, Wakefield LM and Roberts AB . (2003). Cancer Res., 63, 8284–8292.

  • Treisman R . (1996). Curr. Opin. Cell Biol., 8, 205–215.

  • Uchida K, Suzuki H, Ohashi T, Nitta K, Yumura W and Nihei H . (2001). Biochem. Biophys. Res. Commun., 289, 376–381.

  • Ventura JJ, Kennedy NJ, Flavell RA and Davis RJ . (2004). Mol. Cell, 15, 269–278.

  • Verrecchia F, Pessah M, Atfi A and Mauviel A . (2000). J. Biol. Chem., 275, 30226–30231.

  • Verrecchia F, Tacheau C, Schorpp-Kistner M, Angel P and Mauviel A . (2001a). Oncogene, 20, 2205–2211.

  • Verrecchia F, Tacheau C, Wagner EF and Mauviel A . (2003). J. Biol. Chem., 278, 1585–1593.

  • Verrecchia F, Vindevoghel L, Lechleider RJ, Uitto J, Roberts AB and Mauviel A . (2001b). Oncogene, 20, 3332–3340.

  • Wakefield LM and Roberts AB . (2002). Curr. Opin. Genet. Dev., 12, 22–29.

  • Wang T . (2003). Front Biosci., 8, d1109–d1127.

  • Whitmarsh AJ and Davis RJ . (1999). Sci. STKE, 1999, PE1.

  • Wong C, Rougier-Chapman EM, Frederick JP, Datto MB, Liberati NT, Li JM and Wang XF . (1999). Mol. Cell. Biol., 19, 1821–1830.

  • Xiao Z, Watson N, Rodriguez C and Lodish HF . (2001). J. Biol. Chem., 276, 39404–39410.

  • Xie L, Law BK, Aakre ME, Edgerton M, Shyr Y, Bhowmick NA and Moses HL . (2003). Breast Cancer Res., 5, R187–R198.

  • Xie L, Law BK, Chytil AM, Brown KA, Aakre ME and Moses HL . (2004). Neoplasia, 6, 603–610.

  • Yamaguchi K, Nagai S, Ninomiya-Tsuji J, Nishita M, Tamai K, Irie K, Ueno N, Nishida E, Shibuya H and Matsumoto K . (1999). EMBO J., 18, 179–187.

  • Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E and Matsumoto K . (1995). Science, 270, 2008–2011.

  • Yang X, Khosravi-Far R, Chang HY and Baltimore D . (1997). Cell, 89, 1067–1076.

  • Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, Massagué J, Mundy GR and Guise TA . (1999). J. Clin. Invest., 103, 197–206.

  • Yonekura A, Osaki M, Hirota Y, Tsukazaki T, Miyazaki Y, Matsumoto T, Ohtsuru A, Namba H, Shindo H and Yamashita S . (1999). Endocr. J., 46, 545–553.

  • Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace Jr AJ, Liebermann DA, Bottinger EP and Roberts AB . (2003). J. Biol. Chem., 278, 43001–43007.

  • Yoshida K, Matsuzaki K, Mori S, Tahashi Y, Yamagata H, Furukawa F, Seki T, Nishizawa M, Fujisawa J and Okazaki K . (2005). Am. J. Pathol., 166, 1029–1039.

  • Yu L, Hebert MC and Zhang YE . (2002). EMBO J., 21, 3749–3759.

  • Yue J and Mulder KM . (2000). J. Biol. Chem., 275, 35656.

  • Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A and Derynck R . (2001). Proc. Natl. Acad. Sci. USA, 98, 974–979.

  • Zhang Y, Feng XH and Derynck R . (1998). Nature, 394, 909–913.

  • Zhou G, Bao ZQ and Dixon JE . (1995). J. Biol. Chem., 270, 12665–12669.

  • Zhou G, Lee SC, Yao Z and Tan TH . (1999). J. Biol. Chem., 274, 13133–13138.

  • Zimmerman CM and Padgett RW . (2000). Gene, 249, 17–30.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alain Mauviel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Javelaud, D., Mauviel, A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis. Oncogene 24, 5742–5750 (2005). https://doi.org/10.1038/sj.onc.1208928

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208928

Keywords

This article is cited by

Search

Quick links